HoneyNaps Achieves CRO Status to Transform AI-Driven Clinical Trial Analytics

HoneyNaps Achieves CRO Registration for Enhanced Clinical Trials

On July 27, 2026, HoneyNaps announced a significant step forward in its business journey by officially registering as a Contract Research Organization (CRO) with the Korea National Enterprise for Clinical Trials (KoNECT). This milestone not only marks HoneyNaps' commitment to advancing AI-powered analytics for clinical sleep data but also positions the company as a comprehensive resource for pharmaceutical, medical device, and healthcare companies worldwide.

With the growing recognition of sleep as a critical element in clinical research, HoneyNaps is uniquely poised to address the complexities of sleep-related studies. Leveraging its extensive experience, having supported clinical trials with more than 10,000 participants, the company is set to deliver highly accurate and efficient analyses, thus facilitating global multicenter trials.

Expansion of SOMNUM Clinical Services

Central to HoneyNaps’ strategy is the commercialization of its SOMNUM Clinical service, powered by the company’s proprietary AI-based sleep analysis solution, SOMNUM AI. This innovative technology has already received two clearances from the U.S. FDA for its effectiveness in analyzing polysomnography (PSG) data, providing a quantitative assessment of various sleep parameters, including sleep stages and apnea-hypopnea index (AHI).

In traditional research settings, analyzing such sleep data is a labor-intensive process. However, HoneyNaps' SOMNUM Clinical service automates much of this analysis, substantially reducing processing time by more than 90%. This not only enhances the efficiency of clinical trials but also leads to accelerated study timelines.

“Our goal is to improve the understanding of sleep health and its implications across various therapeutic areas including obesity, cardiovascular disease, and mental health,” says Sean Ha, President of HoneyNaps USA. This integrated capacity positions HoneyNaps as a leader in providing advanced AI analytics combined with strong clinical support system.

Market Opportunities and Future Outlook

According to a report by Dataintelo, the global clinical sleep health market is projected to expand from approximately USD 22.8 billion in 2025 to USD 36.9 billion by 2034. This growth is fueled by the increasing acknowledgment of sleep not just as a clinical endpoint for issues like insomnia, but also as a key digital biomarker in broader areas of health research. Key therapeutic areas benefiting from this understanding include obesity, cardiovascular diseases, neurodegenerative disorders, and mental health issues.

SOMNUM Clinical specifically targets operational challenges within sleep-related clinical trials, addressing the pressing need for standardized and objective analyses. By adhering to established scoring criteria set by the American Academy of Sleep Medicine (AASM), the service ensures that sleep metrics are consistently analyzed across multiple study sites. This consistency minimizes variability, thus delivering high-quality clinical data that meets the rigorous standards needed for global multicenter clinical trials.

Commitment to Innovation

HoneyNaps' recent advancements are indicative of the rapidly evolving field of sleep medicine, which is increasingly recognized as a critical component across diverse therapeutic areas. The company's commitment to integrating AI solutions into clinical trial analytics aims to transcend traditional boundaries, facilitating innovative research avenues and promoting the development of effective healthcare solutions.

As the demand for objective and standardized clinical data grows, HoneyNaps positions itself not only as a provider of sleep disorder studies but also as a partner for innovations in pharmaceuticals, wearable devices, and digital therapeutics. With the backing of robust AI analytics and clinical expertise, HoneyNaps aims to establish a formidable presence in the global landscape of AI-driven clinical trial analytics powered by digital biomarkers.

For further information regarding HoneyNaps’ innovative solutions and services, you can visit their official website at HoneyNaps.